Skip to content

Aspiration in chronic obstructive pulmonary disease (COPD)

Aspiration and pulmonary outcomes in chronic obstructive pulmonary disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12620000513910
Enrollment
151
Registered
2020-04-27
Start date
2015-04-10
Completion date
2017-08-25
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to provide proof of concept support for prevalence of aspiration and association with more frequent severe acute exacerbations in chronic obstructive pulmonary disease.

Interventions

Baseline standardised measurements: spirometry, gas transfer, lung volumes by body plethysmography, exhaled nitric oxide (FENO), transcutaneous oximetry, respiratory rate, Airways Questionnaire 20 (AQ20), Eating Assessment Tool-10 (EAT-10), Oral Health Assessment Tool (OHAT), resting pH of unstimulated saliva, auditory perceptual voice evaluation and videofluoroscopy swallowing examination. Radiographic oral barium liquid solution was administered as part of standard videofluoroscopy procedure.

Baseline standardised measurements: spirometry, gas transfer, lung volumes by body plethysmography, exhaled nitric oxide (FENO), transcutaneous oximetry, respiratory rate, Airways Questionnaire 20 (AQ20), Eating Assessment Tool-10 (EAT-10), Oral Health Assessment Tool (OHAT), resting pH of unstimulated saliva, auditory perceptual voice evaluation and videofluoroscopy swallowing examination. Radiographic oral barium liquid solution was administered as part of standard videofluoroscopy procedure. Dose of oral barium solution was 100mL, taken twice within a 5-minute period during initial testing. Assessments were delivered individually by an experienced speech pathologist, respiratory scientists and radiographers within 1.5 hours. Measurements performed at 6 months: above measurements repeated excluding OHAT, resting saliva pH, voice evaluation, respiratory rate and videofluoroscopy swallowing examination. Measurements performed at 12 months: AQ20 and EAT-10 via telephone. Measurements performed at 3, 6, 9, 12 months: Episodes of acute exacerbations of COPD (AECOPD) via telephone interviews using structured AECOPD questionnaire and examination of medical records.

Sponsors

Monash Medical Centre
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Verified diagnosis of COPD made by general practitioner or respiratory physician using international criteria/guidelines. Stable lung disease in the preceding 12 weeks prior to initial/baseline assessments.

Exclusion criteria

Known neurological disease, significant head or neck surgery impacting swallow, history of head or neck cancer, abnormal cranial nerve function on examination, current smokers

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026